The app, which predicts how severe a COVID-19 patient’s case will be, has been evaluated within the Family Health Centers at NYU Langone Health in New York City. The researchers are looking to launch it nationwide in the next few weeks, and COVID-19 severity scores derived from the app could be integrated with hospital EHRs, allowing clinicians to use the assessment tool to support care decisions.
To build the app, the NYU researchers used data from 160 hospitalized patients in Wuhan, China, to pinpoint four biomarkers measured in blood tests that were significantly higher in patients who died than those who recovered. The biomarkers are C-reactive protein, myoglobin, procalcitonin and cardiac troponin I.
Researchers then used the biomarkers and two established risk factors of age and sex to build a machine learning model. When a patient’s biomarkers and risk factors are entered into the AI-powered model, it generates a numerical COVID-19 severity score ranging from zero, mild or moderate to 100, which is critical.
The team used data from 12 hospitalized COVID-19 patients in Shenzhen, China, to validate the model and then further validated it by testing it with data from more than 1,000 New York City COVID-19 patients.
More articles on digital transformation:
AI, facial recognition & virtual communication: How 4 health systems are using tech to guide return to workplace
MassMutual Ventures launches $100M fund for digital health companies and more
OurCrowd’s new $100M fund focuses on pandemic innovations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
